Further, the Company sells tests to a number of domestic and international laboratory partners and identifies the laboratory partners as customers, provided that there is a test services agreement be…
The Company enters into contracts with insurance carriers with primarily payment terms related to tests provided to patients who have health insurance coverage.
Insurance carriers are considered third-party payers on behalf of the patients, and the patients are considered the customers who receive genetic test services.
Natera, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NTRA-DEBT
Debt stack $240.1M
90%
Market cache reports total debt of $240.1M.
NTRA-DEBT-11393
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
NTRA-DEBT-11392
Warrants outstanding: 0.0978
90%
xbrl warrant detail from xbrl 2025-12-31.
Natera, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Natera, Inc..
Natera, Inc. Ownership
Holder
Name
Confidence
Evidence
NTRA-OWNER-JPMORGAN-CHASE-CO
JPMORGAN CHASE & CO
90%
13F overlay lists JPMORGAN CHASE & CO as top holder; 764 tracked holders.
Natera, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.